SCHEMBL8978150

SCHEMBL8978150

CCC1(N)COC(C)(C)OC1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KCNA4 P22459 1/20 0.32
KCNA1 Q09470 1/20 0.32
KCNAB1 Q14722 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24721803 0.79 KCNA4 (0.32) KCNA4KCNA1KCNAB1
SCHEMBL3061881 0.77 EPHX1 (0.39) KCNA4KCNA1KCNAB1
SCHEMBL14778808 0.75
SCHEMBL11824382 0.73
SCHEMBL20434892 0.72 POLB (0.38) KCNA4KCNA1KCNAB1
SCHEMBL11912902 0.72 EPHX1 (0.38) KCNA4KCNA1KCNAB1
Hydrochloric Acid SCHEMBL25250172 0.72
SCHEMBL555211 0.71 KCNA4 (0.37) KCNA4KCNA1KCNAB1
SCHEMBL19425925 0.71 KCNA4 (0.37) KCNA4KCNA1KCNAB1
SCHEMBL10647773 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9044512-B2 Amino alcohol cationic lipids for oligonucleotide delivery SIRNA THERAPEUTICS, INC. (US) 2015-06-02 US disclosed
US-20140323548-A1 NOVEL AMINO ALCOHOL CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY BANK OF AMERICA, N.A. 2014-10-30 US disclosed
US-8802863-B2 Amino alcohol cationic lipids for oligonucleotide delivery SIRNA THERAPEUTICS, INC. (US) 2014-08-12 US disclosed
US-20130150625-A1 Novel Amino Alcohol Cationic Lipids for Oligonucleotide Delivery BANK OF AMERICA, N.A. 2013-06-13 US disclosed
EP-2042532-B1 Polymerizable composition and planographic printing plate precursor using the same, alkalisoluble polyurethane resin, and process for producing diol compound FUJIFILM CORP (JP) 2011-09-14 EP disclosed
US-7741011-B2 Polymerizable composition and planographic printing plate precursor using the same, alkali-soluble polyurethane resin, and process for producing diol compound FUJIFILM CORPORATION (JP) 2010-06-22 US disclosed
US-7741011-B2 Polymerizable composition and planographic printing plate precursor using the same, alkali-soluble polyurethane resin, and process for producing diol compound FUJIFILM CORPORATION (JP) 2010-06-22 US disclosed
US-20090087785-A1 POLYMERIZABLE COMPOSITION AND PLANOGRAPHIC PRINTING PLATE PRECURSOR USING THE SAME, ALKALI-SOLUBLE POLYURETHANE RESIN, AND PROCESS FOR PRODUCING DIOL COMPOUND FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed
US-20090087785-A1 POLYMERIZABLE COMPOSITION AND PLANOGRAPHIC PRINTING PLATE PRECURSOR USING THE SAME, ALKALI-SOLUBLE POLYURETHANE RESIN, AND PROCESS FOR PRODUCING DIOL COMPOUND FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed
EP-2042532-A2 Polymerizable composition and planographic printing plate precursor using the same, alkalisoluble polyrethane resin, an process for producing diol compound FUJIFILM Corporation (JP) 2009-04-01 EP disclosed
US-5482965-A PROMOTERS FOR TRANSDERMAL ADMINISTRATION OF DRUGS RAJADHYAKSHA VITHAL J (US) 1996-01-09 US disclosed
EP-0576605-A4 COMPOSITIONS AND METHOD COMPRISING AMINOALCOHOL DERIVATIVES AS MEMBRANE PENETRATION ENHANCERS RAJADHYAKSHA VITHAL J (US) 1994-06-08 EP disclosed
EP-0576605-A1 COMPOSITIONS AND METHOD COMPRISING AMINOALCOHOL DERIVATIVES AS MEMBRANE PENETRATION ENHANCERS THERAPEUTIC PATCH RESEARCH N.V. (US) 1994-01-05 EP disclosed
WO-1992016236-A1 COMPOSITIONS AND METHOD COMPRISING AMINOALCOHOL DERIVATIVES AS MEMBRANE PENETRATION ENHANCERS RAJADHYAKSHA VITHAL J (US) 1992-10-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130150625-A1 Novel Amino Alcohol Cationic Lipids for Oligonucleotide Delivery CETP, SLC7A5, NPC1L1 KCNA4 3276/4885KCNA1 3938/4885KCNAB1 2333/4885
US-20140323548-A1 NOVEL AMINO ALCOHOL CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY CETP, SLC7A5, NPC1L1 KCNA4 3276/4885KCNA1 3938/4885KCNAB1 2333/4885
US-20090087785-A1 POLYMERIZABLE COMPOSITION AND PLANOGRAPHIC PRINTING PLATE PRECURSOR USING THE SAME, ALKALI-SOLUBLE POLYURETHANE RESIN, AND PROCESS FOR PRODUCING DIOL COMPOUND PAH, RPN1, RER1 KCNA4 4154/4885KCNA1 3728/4885KCNAB1 3830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.